Patents by Inventor Erland Stevens

Erland Stevens has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR THE TREATMENT OF METABOLIC AND LIVER DISORDERS
    Publication number: 20240058415
    Abstract: Disclosed herein are small molecule GIP/GLP-1 dual receptor agonist compositions, pharmaceutical compositions, the use and preparation thereof.
    Type: Application
    Filed: August 10, 2023
    Publication date: February 22, 2024
    Inventors: Brian Lian, Geoffrey E. Barker, Maureen Barnes, Kader Yagiz, Erland Stevens
  • Compositions and methods for the treatment of metabolic and liver disorders
    Patent number: 11744873
    Abstract: Disclosed herein are small molecule GIP/GLP-1 dual receptor agonist compositions, pharmaceutical compositions, the use and preparation thereof.
    Type: Grant
    Filed: November 18, 2022
    Date of Patent: September 5, 2023
    Assignee: Viking Therapeutics, Inc.
    Inventors: Brian Lian, Geoffrey E. Barker, Maureen Barnes, Kader Yagiz, Erland Stevens
  • COMPOSITIONS AND METHODS FOR THE TREATMENT OF LIVER DISORDERS
    Publication number: 20230226038
    Abstract: The present disclosure is directed to FXR agonists, pharmaceutical compositions thereof, and methods of using the same for preventing, treating, or ameliorating fatty liver diseases such as steatosis, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis, either alone or in combination with thyroid receptor agonists.
    Type: Application
    Filed: June 7, 2021
    Publication date: July 20, 2023
    Inventors: Brian Lian, Geoffrey E. Barker, Kader Yagiz, Maureen Barnes, Erland Stevens
  • COMPOSITIONS AND METHODS FOR THE TREATMENT OF METABOLIC AND LIVER DISORDERS
    Publication number: 20230105647
    Abstract: Disclosed herein are small molecule GIP/GLP-1 dual receptor agonist compositions, pharmaceutical compositions, the use and preparation thereof.
    Type: Application
    Filed: November 18, 2022
    Publication date: April 6, 2023
    Inventors: Brian Lian, Geoffrey E. Barker, Maureen Barnes, Kader Yagiz, Erland Stevens